Skip to main content
Top
Published in: International Journal of Bipolar Disorders 1/2013

Open Access 01-12-2013 | Short communication

Bipolar disorders in DSM-5: strengths, problems and perspectives

Author: Jules Angst

Published in: International Journal of Bipolar Disorders | Issue 1/2013

Login to get access

Abstract

The diagnostic classification of mood disorders by the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR) had two major shortcomings: an underdiagnosis of bipolar disorders and a large proportion of treated patients had to be allocated to the vague NOS groups ‘not otherwise specified’. Several new subthreshold groups of depression, bipolar disorders and mixed states are now operationally defined in DSM-5. In addition, hypomanic and manic episodes occurring during antidepressant treatments are, under certain conditions, accepted as criteria for bipolar disorders. The diagnosis of bipolarity now requires, as entry criterion A, not only the presence of elated or irritable mood but also the association of these symptoms with increased energy/activity. This restriction will unfortunately change the diagnoses of some patients from DSM-IV bipolar I and II disorders to subdiagnostic bipolar syndromes. Nonetheless, overall, DSM-5 is a step in the right direction, specifying more subdiagnostic categories with an improved dimensional approach to severity. DSM-5 may also have an impact on patient selection for placebo-controlled drug trials with antidepressants.
Literature
go back to reference Angst J, Gamma A, Gerber-Werder R, Zarate CA Jr, Manji HK: Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients? Int J Psychiatr Clin Pract. 2007, 11: 2–8. 10.1080/13651500600810133CrossRef Angst J, Gamma A, Gerber-Werder R, Zarate CA Jr, Manji HK: Does long-term medication with lithium, clozapine or antidepressants prevent or attenuate dementia in bipolar and depressed patients? Int J Psychiatr Clin Pract. 2007, 11: 2–8. 10.1080/13651500600810133CrossRef
go back to reference Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Rössler W, Regier D: Subjective distress predicts treatment seeking for depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra. Acta Psychiatr Scand. 2010, 122: 488–98. 10.1111/j.1600-0447.2010.01580.xPubMedCrossRef Angst J, Gamma A, Clarke D, Ajdacic-Gross V, Rössler W, Regier D: Subjective distress predicts treatment seeking for depression, bipolar, anxiety, panic, neurasthenia and insomnia severity spectra. Acta Psychiatr Scand. 2010, 122: 488–98. 10.1111/j.1600-0447.2010.01580.xPubMedCrossRef
go back to reference Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, Young AH: Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci. 2012, 262: 3–11. 10.1007/s00406-011-0228-0PubMedCrossRef Angst J, Gamma A, Bowden CL, Azorin JM, Perugi G, Vieta E, Young AH: Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes. Eur Arch Psychiatry Clin Neurosci. 2012, 262: 3–11. 10.1007/s00406-011-0228-0PubMedCrossRef
go back to reference Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M, Zisook S: Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord. 2012, 127: 10–8.CrossRef Correa R, Akiskal H, Gilmer W, Nierenberg AA, Trivedi M, Zisook S: Is unrecognized bipolar disorder a frequent contributor to apparent treatment resistant depression? J Affect Disord. 2012, 127: 10–8.CrossRef
go back to reference da Silva J, Gonçalves-Pereira M, Xavier M, Mukaetova-Ladinska EB: Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013, 202: 177–86. 10.1192/bjp.bp.111.101931PubMedCrossRef da Silva J, Gonçalves-Pereira M, Xavier M, Mukaetova-Ladinska EB: Affective disorders and risk of developing dementia: systematic review. Br J Psychiatry. 2013, 202: 177–86. 10.1192/bjp.bp.111.101931PubMedCrossRef
go back to reference Hantouche E, Azorin JM, Lancrenon S, Garay R-P, Angst J: Prévalence de l'hypomanie dans les dépressions majeures récurrentes ou résistantes: enquêtes Bipolact. Ann Med Psychol. 2009, 167: 30–7. Hantouche E, Azorin JM, Lancrenon S, Garay R-P, Angst J: Prévalence de l'hypomanie dans les dépressions majeures récurrentes ou résistantes: enquêtes Bipolact. Ann Med Psychol. 2009, 167: 30–7.
go back to reference Kessing LV, Sondergard L, Forman JL, Andersen PK: Lithium treatment and risk of dementia. Arch Gen Psychiatry. 2008, 65: 1331–5. 10.1001/archpsyc.65.11.1331PubMedCrossRef Kessing LV, Sondergard L, Forman JL, Andersen PK: Lithium treatment and risk of dementia. Arch Gen Psychiatry. 2008, 65: 1331–5. 10.1001/archpsyc.65.11.1331PubMedCrossRef
go back to reference Merikangas KR, Cui L, Kattan G, Carlson G, Youngstrom EA, Angst J: Mania with and without depression in a community sample of U.S. adolescents. Arch Gen Psychiat. 2012, 69: 943–51. 10.1001/archgenpsychiatry.2012.38PubMedCrossRef Merikangas KR, Cui L, Kattan G, Carlson G, Youngstrom EA, Angst J: Mania with and without depression in a community sample of U.S. adolescents. Arch Gen Psychiat. 2012, 69: 943–51. 10.1001/archgenpsychiatry.2012.38PubMedCrossRef
go back to reference Merikangas KR, Lihong C, Heaton L, Nakamura E, Roca C, Ding J, Qin H, Yao Y, Zarate CA, Angst J: Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry. . In press Merikangas KR, Lihong C, Heaton L, Nakamura E, Roca C, Ding J, Qin H, Yao Y, Zarate CA, Angst J: Independence of familial transmission of mania and depression: results of the NIMH family study of affective spectrum disorders. Mol Psychiatry. . In press
go back to reference Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, Poulton R: How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010, 40: 899–909. 10.1017/S0033291709991036PubMedCentralPubMedCrossRef Moffitt TE, Caspi A, Taylor A, Kokaua J, Milne BJ, Polanczyk G, Poulton R: How common are common mental disorders? Evidence that lifetime prevalence rates are doubled by prospective versus retrospective ascertainment. Psychol Med. 2010, 40: 899–909. 10.1017/S0033291709991036PubMedCentralPubMedCrossRef
go back to reference Nunes PV, Forlenza OV, Gattaz WF: Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry. 2007, 190: 359–60. 10.1192/bjp.bp.106.029868PubMedCrossRef Nunes PV, Forlenza OV, Gattaz WF: Lithium and risk for Alzheimer's disease in elderly patients with bipolar disorder. Br J Psychiatry. 2007, 190: 359–60. 10.1192/bjp.bp.106.029868PubMedCrossRef
go back to reference Päären A, von Knorring A-L, Olsson G, Von Knorring L, Bohman H, Jonsson U: Hypomania spectrum disorders from adolescence to adulthood: a 15-year follow-up of a community sample. J Affect Disord. 2013, 145: 190–9. 10.1016/j.jad.2012.07.031PubMedCrossRef Päären A, von Knorring A-L, Olsson G, Von Knorring L, Bohman H, Jonsson U: Hypomania spectrum disorders from adolescence to adulthood: a 15-year follow-up of a community sample. J Affect Disord. 2013, 145: 190–9. 10.1016/j.jad.2012.07.031PubMedCrossRef
go back to reference Phillips ML, Kupfer DJ: Bipolar disorder diagnosis: challenges and future directions. Lancet. 2013, 381: 1663–71. 10.1016/S0140-6736(13)60989-7PubMedCrossRef Phillips ML, Kupfer DJ: Bipolar disorder diagnosis: challenges and future directions. Lancet. 2013, 381: 1663–71. 10.1016/S0140-6736(13)60989-7PubMedCrossRef
go back to reference Post RM, Kalivas P: Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013, 202: 172–6. 10.1192/bjp.bp.112.116855PubMedCentralPubMedCrossRef Post RM, Kalivas P: Bipolar disorder and substance misuse: pathological and therapeutic implications of their comorbidity and cross-sensitisation. Br J Psychiatry. 2013, 202: 172–6. 10.1192/bjp.bp.112.116855PubMedCentralPubMedCrossRef
go back to reference Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970, 126: 983–7.PubMedCrossRef Robins E, Guze SB: Establishment of diagnostic validity in psychiatric illness: its application to schizophrenia. Am J Psychiatry. 1970, 126: 983–7.PubMedCrossRef
go back to reference Rybakowski JK, Angst J, Dudek D, Pawlowski T, Lojko D, Siwek M, Kiejna A: Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur Arch Psychiat Neurol Sci. 2010, 260: 139–44. 10.1007/s00406-009-0030-4CrossRef Rybakowski JK, Angst J, Dudek D, Pawlowski T, Lojko D, Siwek M, Kiejna A: Polish version of the Hypomania Checklist (HCL-32) scale: the results in treatment-resistant depression. Eur Arch Psychiat Neurol Sci. 2010, 260: 139–44. 10.1007/s00406-009-0030-4CrossRef
Metadata
Title
Bipolar disorders in DSM-5: strengths, problems and perspectives
Author
Jules Angst
Publication date
01-12-2013
Publisher
Springer Berlin Heidelberg
Published in
International Journal of Bipolar Disorders / Issue 1/2013
Electronic ISSN: 2194-7511
DOI
https://doi.org/10.1186/2194-7511-1-12

Other articles of this Issue 1/2013

International Journal of Bipolar Disorders 1/2013 Go to the issue